Rationale: In addition to their well-known function as antibodyproducing cells, B lymphocytes can markedly influence the course of infectious or noninfectious diseases via antibody-independent mechanisms. In tuberculosis (TB), B cells accumulate in lungs, yet their functional contribution to the host response remains poorly understood.
Infection with Mycobacterium tuberculosis (Mtb) leads to the formation of lung lesions, the granulomas, which contain macrophages and other cell types and are surrounded by various lymphocyte populations, including B lymphocytes (1) (2) (3) (4) . The presence of B cells at the site of infection suggests that they may contribute to host-pathogen interaction locally.
Several studies attempted to delineate the antibody-mediated roles of B cells and the impact of their total deficiency in tuberculosis (TB) (5) (6) (7) (8) (9) (10) . Studies performed with B cell-deficient mice yielded conflicting results, with some studies concluding that B cells played no apparent function in TB and others concluding that B cells contributed to protection against Mtb (2, 6, 8, 11, 12) . In humans, the depletion of B cells in patients treated with rituximab did not increase the risk of TB reactivation (13, 14) , and in macaques rituximab administration to Mtb-infected animals had limited effects at the individual granuloma level (15) . These studies suggest a moderate role for B cells in immunity to Mtb. However, they used approaches that might not be suitable to reveal more complex functions of B cells, in particular those mediated through the production of cytokines, whose relevance during infection by intracellular bacterial pathogens has received increasing experimental evidence (16) (17) (18) . Indeed, B cells can play either favorable or detrimental roles during infection, depending on the cytokines they produce, and the depletion of the whole B-cell compartment may not be suitable to reveal such potentially antagonistic B-cell activities. The aim of our study was to investigate the eventual antibodyindependent functions of B cells in an unbiased manner. For this, we analyzed the transcriptome of B cells isolated from the lungs and spleen of Mtb-infected mice. This revealed a STAT1 (signal transducer and activator of transcription 1)-centered signature, which pointed to the ability of B cells to both produce and respond to type I IFN. We identified STING (stimulator of interferon genes) and Mincle Author Contributions: A.B. performed most of the experiments and data analysis, designed the study, and wrote the manuscript. I.S., P.S., A.C., L.T., B.G., and T.A.-S. contributed to some experiments. I.M., L.J., P.B., and V.A.-L. performed the microarray data analysis. P.S., R.L., J.R., M.D.C.S., A.G.L., and A.O'G. provided key biological material. S.H.E.K. helped with the writing of the manuscript. S.F., O.N., and D.H. designed the study, performed some experiments, and wrote the manuscript. Figure 1A ; see Table E1 in the online supplement) compared with naive controls. Ingenuity Pathway Analysis indicated that the differentially expressed genes formed a network centered on STAT1, a master transcription factor of the IFN response ( Figure 1B) . The higher expression of the STAT1 signature genes Stat1 (signal transducer and activator of transcription 1), Irgm1 (immunity-related GTPase family M member 1), Csf1 (colonystimulating factor 1), Ccrl2 (C-C motif chemokine receptor-like 2), Ccl5 (C-C motif chemokine ligand 5), and Cxcl9 (C-X-C motif chemokine ligand 9) in B cells from the lungs of infected mice was confirmed by quantitative reverse transcriptase-polymerase chain reaction ( Figures 1C and 1D ). Figure 2C ). Taken together, these data suggest that B cells were exposed to type I IFN in infected mice. Because type I IFN could act in an autocrine manner (21), we next investigated whether B cells expressed type I IFN during infection. B cells isolated from the lungs and spleen of infected mice indeed displayed a massive up-regulation of the Ifnb transcripts, compared with B cells from naive mice ( Figure 2D ). In comparison, the levels of Il-6 and Il-10 mRNA, which have previously been identified as important mediators of the antibody-independent functions of B cells in other diseases (16, 19) , showed only a modest increase (although significant in for Il-6) ( Figure 2D Figure  E1 ), underlining a rapid innate response. B cell-derived type I IFN protein was detected in the B-cell culture supernatants using a type I IFN-specific reporter cell line ( Figure 2G ) and ELISA ( Figure 2H ). Type I IFN amplified its induction in an autocrine manner, because its expression was markedly reduced in B cells lacking the type I IFN receptor subunit IFNAR1 ( Figure 2I ). B-cell infection per se was not necessary, as filtered supernatants from Mtb cultures also induced type I IFN expression in B cells, implicating secreted Mtb components in this process ( Figure 2J ). We conclude that B cells produce and respond to type I IFN during Mtb infection.
Type I IFN Expression in Mtb-stimulated B Cells Involves Innate Receptors
We next sought to identify the molecular mechanisms controlling type I IFN expression in B cells exposed to Mtb and tested the involvement of distinct innate sensors. The cytosolic dinucleotide sensor STING (22, 23) contributed to type I IFN expression in B cells stimulated with Mtb or cyclic-di-AMP (c-di-AMP), a secreted mycobacterial STING ligand ( Figures  3A-3D ) (22, 24) . In addition, the C-type lectin Mincle (25) also contributed to type I IFN expression in B cells stimulated with Mtb, albeit to a lower extent than STING ( Figure E2 ). We thus used c-di-AMP to further address which B-cell subset(s) contributed to this response. CD21 , and Csf1 genes found to be up-regulated in the transcriptome of B cells purified from the spleen of naive mice or from spleen and lung of Mtb-infected C57BL/6 mice. (For each sample, B cells were pooled from three independent mice. Four to five independent infection experiments were performed.) (D) As in C, except that the Ccrl2, Ccl5, and Cxcl9 genes were analyzed. Data represent mean 6 SEM and were analyzed by the two-tailed Mann-Whitney test. *P < 0.05; **P < 0.01. compared with B cells purified from the blood of healthy donors or patients with TB, indicating that this response was particularly present in infected lungs during disease ( Figure 5D ). PF B cells also responded to type I IFN in vivo, because they displayed an increased expression of BST2 (bone marrow stromal cell antigen 2) and CXCL10 ( Figures 5E and 5F ), two genes belonging to the type I IFN signature in patients with active TB (29 Figure 6A ), which depended on type I IFN ( Figure 6B) . A profound IFNAR1-dependent induction of IFN-stimulated genes, including Ccl2 and Tnfsf10 (tumor necrosis factor superfamily member 10), was also triggered in treated macrophages ( Figure E3 ). In addition, these macrophages displayed an enhanced expression of the regulatory/antiinflammatory molecules PD-L1 (programmed death-ligand 1) and IL-10 ( Figure 6C and 6D, Figure E4 ) as well as a decreased production of IL-1b ( Figure E4B) . A similar IFNAR-1-dependent expression profile was triggered in macrophages treated with the supernatant of c-di-AMP-stimulated B cells, confirming the involvement of type I IFN triggered by STING in this altered macrophage polarization ( Figure  E5 ). Similarly, supernatant of Mtbactivated human B cells induced human macrophages to express IFN-stimulated genes, such as CCL2 ( Figure 6E ) and PD-L1 ( Figures 6F and 6G ). 2/2 B cells were used (n = 4). Data represent mean 6 SEM and were analyzed by using the two-tailed Mann-Whitney test or the two-tailed Wilcoxon test (B-E) (*P < 0.05; **P < 0.01; ***P < 0.001). The two-tailed Student paired t test was used for A and F ( # P < 0.05; ## P < 0.01; ### P < 0.001). TDB = trehalose-6,6-dibehenate.
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Excessive production of type I IFN by B cells is associated with altered macrophage polarization in the lungs of Mtb-infected mice. Because increased levels of type I IFN were associated with clinical TB (29) , and because B cells from the PF of patients with TB expressed high levels of type I IFN ( Figure 5D ), we investigated the consequence of type I IFN overexpression in B cells in the mouse. To generate a model in which only B cells overexpress type I IFN, we took advantage of the fact that type I IFN production by B cells was inhibited by MyD88 signaling. Therefore, we generated mixed bone marrow chimera (34, 35) , in which only B cells lacked MyD88 (B-Myd88 
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int cells from infected mice revealed that they expressed high levels of Arg1 (arginase 1), Cox2, iNOS (inducible nitric oxide synthase), and Ym1 compared with "classical" macrophages ( Figure 7D ). These data suggest that B-Myd88 2/2 mice display an increased accumulation of antiinflammatory monocytes/macrophages compared with control mice. In keeping with this, they also showed in total lung an increased expression of genes characteristic of antiinflammatory and tissue repair-driving M2 macrophages, such as Ym1 and Mrc1 (mannose receptor C-type 1) (37, 38) ( Figure 7E) , with other genes associated with M2 macrophages showing a similar trend to increased expression (Fizz1 [found in inflammatory zone 1]) or unaffected (Arg1) (Figure 7E ), compared with controls. In contrast, the proinflammatory genes Ifng, Tnfa (tumor necrosis factor a), Nos2, and Irgm1 were expressed at lower levels in infected chimeric animals than in controls ( Figure 7E ). These data are therefore consistent with our initial hypothesis that B-Myd88 2/2 mice would, as a result of excessive type I IFN production by B cells, show an altered macrophage polarization toward an Each symbol represents an independent donor (n = 6-7 individuals per group). The expression level was arbitrarily set to 1 for one sample from the peripheral blood of healthy donors group, and the values for the other samples were calculated relative to this reference. Data represent mean 6 SEM and were analyzed using the two-tailed Mann-Whitney test or the two-tailed Wilcoxon test (*P < 0.05; **P < 0.01; ***P < 0.001) except for panels A, B, and F, where a two-tailed Student paired t-test was used ( # P < 0.05; ## P < 0.01). HD = healthy donor.
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antiinflammatory/regulatory profile. This B cell-mediated effect specifically affected macrophages, because similar frequencies of infiltrating T (both CD4 1 and CD8 1 ) and B cells were observed in B-Myd88 2/2 mice compared with their B-WT counterparts ( Figure E6A ). Of note, the altered macrophage phenotype in B-Myd88 2/2 was associated with slightly increased Mtb loads ( Figure E6B ) and reduced signs of inflammation in lungs ( Figure E6C ). Collectively, our data reveal that innate production of type I IFN by B cells correlates with an altered polarization of lung macrophages during Mtb infection. 2/2 mice (n = 3). Data represent mean 6 SEM, are representative of two independent experiments, and were analyzed using the two-tailed Mann-Whitney test. *P < 0.05; **P < 0.01; ***P < 0.001 except for C, where a two-tailed Student paired t-test was used ( # P < 0.05). cfu = colony-forming units; CTRL = control. (29, 30, 40) , but similar to the situation reported in blood T cells of patients with TB (31). We can think of three possible explanations for the local expression of type I IFN in TB. First, it is possible that lymphocytes are in nonresponsive state specifically in blood in TB. This would be consistent with the fact that peripheral B cells from patients with TB have been reported to be hyporesponsive to stimulation (41) . Alternatively, this might reflect a preferential trapping of modulated lymphocytes in the lungs and possibly secondary lymphoid organs, whereas modulated myeloid cells might be more prone to circulate from the affected tissue to the blood. Finally, this might indicate a different threshold of activation for B cells and myeloid cells by Mtb, so that B cells only respond to Mtb-derived molecules when these are present at a high concentration such as in the infected lung, but not in the blood, whereas myeloid cells might be able to respond to the lower microbial compound concentrations in blood. Thus, our data suggest that type I IFN production by B cells might be important locally, at the site of TB infection and inflammation. B cells are known to be in close proximity to other immune cells, including monocytes and macrophages, in the lungs of patients with TB or infected animals (3, 31) . Our in vitro data unambiguously demonstrate that Mtb-stimulated B cells drive macrophage polarization toward an antiinflammatory profile in a type I IFN-dependent manner. B cells were previously reported to modulate macrophage polarization in various models of infection, autoimmunity, and cancer (18, 32, 42) . In particular, B cells polarized macrophages toward an alternatively activated M2 state through IL-10 production in a murine melanoma model (42) . By contrast, a similar action of B cells on macrophages was reported to be independent of IL-10 in the context of TB (33) . Our data provide direct evidence that type I IFN produced by Mtb-stimulated B cells contributes to macrophage polarization in vitro, which might explain this apparent discrepancy. This is in agreement with our in vivo data showing that overproduction of type I IFN by B cells in a mouse model of B cell-restricted Myd88 deficiency correlates with the accumulation of antiinflammatory/ regulatory macrophages during Mtb infection in infected lungs, which is locally associated with increased bacterial burden and reduced pathology.
Overexpression of type I IFN is generally detrimental in TB (43, 44) . In particular, hypervirulent strains of Mtb induce increased production of type I IFN (45, 46) , and patients with active TB disease show a type I IFN-inducible gene expression profile in their blood cells (29, 47) . Among the proposed mechanisms for the detrimental action of type I IFN in TB is the induction of IL-10 secretion by myeloid cells and macrophages, which leads to a reduced expression of protective IL-12 and tumor necrosis factor-a (28, 43) , as well as an increased induction of myeloid-derived suppressor cells (36, 48) (37) . Because MyD88 signaling controls the production of IL-6 and IL-10 by B cells (49), we cannot exclude that these cytokines play a part in the observed phenotype. However, beyond the fact that the major cellular changes observed in B-Myd88 2/2 mice are known to be inducible by type I IFN, we do not favor this possibility, because Il6 and Il10 mRNA were only induced at modest levels in B cells isolated from the lungs of wild-type mice, and it is most likely that their expression was even lower in Myd88-deficient B cells.
Overall, hyperproduction of type I IFN production by B cells correlates with increased Mtb burden in lungs, which suggests that this B-cell activity negatively affects the control of bacterial replication and is in agreement with the belief that type I IFNs are detrimental in TB. How low concentrations of type I IFN can induce significant biological responses is a complex question, whose answer likely rests on parameters such as the diversity of type I IFNs, their differential affinity for the IFNAR receptor, the properties of type I IFN signaling pathways, and the timing and duration of expression (50) . In conclusion, our study reveals type I IFN production as a novel antibody-independent function of B cells in immunity to TB. n Author disclosures are available with the text of this article at www.atsjournals.org.
